C Mazzaro

Summary

Country: Italy

Publications

  1. ncbi request reprint Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection
    Cesare Mazzaro
    J Clin Oncol 23:4470-1; author reply 4471. 2005
  2. ncbi request reprint Role of the HLA class II: HCV-related disorders
    Valli De Re
    CRO IRCCS, Aviano National Cancer Institute, Pordenone, Italy
    Ann N Y Acad Sci 1107:308-18. 2007
  3. ncbi request reprint Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma
    C Mazzaro
    Third Department of Medicine, General Hospital of Pordenone, Italy
    Ital J Gastroenterol Hepatol 30:428-34. 1998
  4. ncbi request reprint Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study
    Cesare Mazzaro
    Department of Internal Medicine, Pordenone General Hospital, Via Montereale 24, 33170 Pordenone PN, Italy
    J Hepatol 42:632-8. 2005
  5. ncbi request reprint Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study
    Cesare Mazzaro
    Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy
    Clin Exp Rheumatol 29:933-41. 2011
  6. doi request reprint Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature
    C Ferri
    Rheumatology Unit, Department of Internal Medicine, University of Modena e Reggio Emilia, Medical School, Via del Pozzo 71, Modena, Italy
    Autoimmun Rev 11:48-55. 2011
  7. ncbi request reprint Hepatitis C virus and non-Hodgkin's lymphoma 10 years later
    C Mazzaro
    Second Department of Medicine, Pordenone General Hospital, Pordenone, Italy
    Dig Liver Dis 37:219-26. 2005
  8. ncbi request reprint Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon
    C Mazzaro
    Third Division of Medicine, Pordenone General Hospital, Italy
    Clin Exp Rheumatol 20:27-34. 2002
  9. ncbi request reprint Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus
    V De Re
    CRO IRCCS, Aviano National Cancer Institute, Pordenone, Italy
    Dig Liver Dis 39:S65-71. 2007
  10. ncbi request reprint Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia
    Cesare Mazzaro
    Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy
    Dig Liver Dis 39:S102-6. 2007

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection
    Cesare Mazzaro
    J Clin Oncol 23:4470-1; author reply 4471. 2005
  2. ncbi request reprint Role of the HLA class II: HCV-related disorders
    Valli De Re
    CRO IRCCS, Aviano National Cancer Institute, Pordenone, Italy
    Ann N Y Acad Sci 1107:308-18. 2007
    ....
  3. ncbi request reprint Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma
    C Mazzaro
    Third Department of Medicine, General Hospital of Pordenone, Italy
    Ital J Gastroenterol Hepatol 30:428-34. 1998
    ..The possible aetiopathogenetic role of hepatitis C virus in non-Hodgkin's lymphomas is discussed on the basis of molecular, clinical and epidemiological considerations...
  4. ncbi request reprint Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study
    Cesare Mazzaro
    Department of Internal Medicine, Pordenone General Hospital, Via Montereale 24, 33170 Pordenone PN, Italy
    J Hepatol 42:632-8. 2005
    ..The aim of this study is to verify the efficacy and safety of peg-interferon alfa-2b in combination with ribavirin for initial treatment of HCV-associated mixed cryoglobulinemia...
  5. ncbi request reprint Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study
    Cesare Mazzaro
    Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy
    Clin Exp Rheumatol 29:933-41. 2011
    ..The aim of the present study is to provide information on clinical outcome of the patients affected by HCV-positive mixed cryoglobulinemia (MC) treated with PEG-IFN and Ribavirin for 6 or 12 months according to the HCV genotype...
  6. doi request reprint Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature
    C Ferri
    Rheumatology Unit, Department of Internal Medicine, University of Modena e Reggio Emilia, Medical School, Via del Pozzo 71, Modena, Italy
    Autoimmun Rev 11:48-55. 2011
    ..This multicenter study retrospectively evaluated the effects of rituximab in a large series of patients with active MCs. The observed results were compared to those emerging from the updated review of the literature on this topic...
  7. ncbi request reprint Hepatitis C virus and non-Hodgkin's lymphoma 10 years later
    C Mazzaro
    Second Department of Medicine, Pordenone General Hospital, Pordenone, Italy
    Dig Liver Dis 37:219-26. 2005
    ..Whether to treat low-grade hepatitis C virus-related lymphomas with anti-viral therapy is still debatable, but encouraging data emerge from some recent studies...
  8. ncbi request reprint Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon
    C Mazzaro
    Third Division of Medicine, Pordenone General Hospital, Italy
    Clin Exp Rheumatol 20:27-34. 2002
    ..The aim of this study was to evaluate the effectiveness of leukocyte interferon as a second-line therapy in patients who are non-responders or relapsers to a first course of recombinant interferon...
  9. ncbi request reprint Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus
    V De Re
    CRO IRCCS, Aviano National Cancer Institute, Pordenone, Italy
    Dig Liver Dis 39:S65-71. 2007
    ..The work was performed in accordance with the principles of the 1983 Declaration of Helsinki. There is no conflict of interest...
  10. ncbi request reprint Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia
    Cesare Mazzaro
    Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy
    Dig Liver Dis 39:S102-6. 2007
    ..New drug combinations, like peginterferons plus anti-CD20 antibodies, should be considered for treatment of MC in the future...
  11. ncbi request reprint Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon
    Cesare Mazzaro
    Second Medical Unit, S Maria degli Angeli Hospital, Pordenone, Italy
    J Rheumatol 30:1775-81. 2003
    ....
  12. ncbi request reprint Regression of splenic lymphoma after treatment of hepatitis C virus infection
    Cesare Mazzaro
    N Engl J Med 347:2168-70; author reply 2168-70. 2002
  13. ncbi request reprint Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias
    Giuseppe Monti
    Unità Operativa di Medicina Generale, Saronno Hospital, Italy
    Arch Intern Med 165:101-5. 2005
    ..Some patients with cryoglobulinemic syndrome (CS) develop frank non-Hodgkin lymphoma (NHL), but the incidence and timing of this event are still poorly defined...
  14. ncbi request reprint Efficacy and safety of rituximab in type II mixed cryoglobulinemia
    Francesco Zaja
    Division of Hematology Dipartimento di Ricerche Mediche e Morfologiche, University of Udine, Italy
    Blood 101:3827-34. 2003
    ..Rituximab may represent a safe and effective alternative to standard immunosuppression in type II MC. Controlled studies are needed to better define drug indications and the cost-efficacy profile in the different systemic manifestations...